Quantitative analysis of the immunostaining revealed that TROP2 expression was significantly increased in COPD relative to nonsmoker and smoker controls as well as in smoker controls relative to nonsmokers (P < 0.01 for all; Fig. 1b). The gene discussed is TACSTD2; the disease is chronic obstructive pulmonary disease.